| Literature DB >> 28960151 |
Shuhei Morita1, Masayuki Nitta1,2, Yoshihiro Muragaki1,2, Takashi Komori3, Kenta Masui4, Takashi Maruyama1,2, Koichi Ichimura5, Yoshiko Nakano5, Tatsuo Sawada4, Shunichi Koriyama1, Shunsuke Tsuzuki1, Takayuki Yasuda1, Kazutoshi Hashimoto1, Akihiro Niwa1, Takakazu Kawamata1.
Abstract
In this report, the authors present the first case of adult brainstem pilocytic astrocytoma (PA) with the H3 K27M mutation. A 53-year-old man was incidentally found to have a 2.5-cm partially enhanced tumor in the tectum on MRI. The enhancement in the lesion increased over 3 years, and gross-total removal was performed via the occipital transtentorial approach. The resected tissue indicated PA, WHO Grade I, and genetic analysis revealed the H3 K27M mutation. However, although the radiological, surgical, and pathological findings all corresponded to PA, this entity can easily be misdiagnosed as diffuse midline glioma with the H3 K27M mutation, which is classified as a WHO Grade IV tumor according to the updated classification. This case highlights the phenotypic spectrum of PA, as well as the biology of the H3 K27M-mutated gliomas, and may prove to be an exception to the rule that diffuse midline gliomas with the H3 K27M mutation behave in an aggressive manner. Based on the findings of this case, the authors conclude that, in addition to detecting the existence of the H3 K27M mutation, an integrated approach in which a combination of clinical, pathological, and genetic information is used should be applied for accurate diagnosis and determination of the appropriate treatment for diffuse midline gliomas.Entities:
Keywords: H3 = histone 3; H3 K27M mutation; MET-PET = methionine-PET; PA = pilocytic astrocytoma; diffuse midline glioma; oncology; pilocytic astrocytoma
Mesh:
Substances:
Year: 2017 PMID: 28960151 DOI: 10.3171/2017.4.JNS162443
Source DB: PubMed Journal: J Neurosurg ISSN: 0022-3085 Impact factor: 5.115